---
document_datetime: 2023-09-21 18:53:38
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/procomvax-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
document_name: procomvax-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 1.7335824
conversion_datetime: 2025-12-19 05:58:58.219167
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
## For procedures finalised before 01/09/2004, please refer to module 8A

## MAJOR CHANGES 1

<!-- image -->

| No      | Scope                                                                                                                                                                                                                                                                                                                                              | Opinion issued on   | Commission Decision Issued/ amended on   | Product Information affected 2   | Summary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------|------------------------------------------|----------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0030 | Change(s) to shelf-life or storage conditions                                                                                                                                                                                                                                                                                                      | 24/07/2008          | 31/07/2008                               |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| II/0029 | Change(s) to the manufacturing process for the active substance Change(s) to the test method(s) and/or specifications for the active substance                                                                                                                                                                                                     | 24/04/2008          | 05/05/2008                               | no                               | longer                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| II/0027 | Change(s) to shelf-life or storage conditions                                                                                                                                                                                                                                                                                                      | 24/01/2008          | 30/01/2008                               |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| II/0028 | product Update of Summary of Product Characteristics Update of sections 4.4 and 4.8 of the SPC to implement the class labelling text on the risk of apnoea following vaccination of very prematurely born infants agreed by the CHMP in July 2007. In addiction the MAHtook the opportunity to update the list of local representatives in the PL. | 15/11/2007          | 11/12/2007                               | SPC                              | Following a review on the risk of apnoea in very premature infants after immunisation the CHMP recommended a class labelling on apnoea for all vaccines in very premature infants. The SPC was updated to include information about the potential risk of apnoea and the need for respiratory monitoring for 48-72h, when the primary immunisation series is administered to very premature infants (born ? 28 weeks of gestation) and particularly for those with a previous history of respiratory immaturity. As the benefit of the vaccination is high in this group of infants, vaccination should not be withheld or delayed. |

1 Major changes e.g. Type II variations, Annex II applications, Renewals and Annual Reassessments

2 SPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet)

<!-- image -->

Medicinal product no longer authorised 1/2 Procomvax Procedural steps taken and scientific information after the authorisation Changes made after 01/09/2004

<div style=\"page-break-after: always\"></div>

<!-- image -->

| A20/0020   | Article 20 Review On 13 February 2006, the European Commission triggered the procedure under Article 20 of Regulation (EC) No726/2004, after the CHMP expressed concerns on the low immunogenicity of the HepB vaccine component. The CHMP was requested to give an opinion as to whether the MAfor Procomvax should be maintained, varied, suspended or withdrawn.   | 27/04/2006   | 28/07/2006   | SPC, Annex II, Labelling, PL   | authorised Please refer to the Scientific Discussion: Procomvax-H-C-231-A20-20-SC   |
|------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|--------------------------------|-------------------------------------------------------------------------------------|
| II/0019    | Change(s) to the test method(s) and/or specifications for the active substance                                                                                                                                                                                                                                                                                        | 15/09/2005   | 22/09/2005   |                                |                                                                                     |
| II/0017    | Change(s) to shelf-life or storage conditions                                                                                                                                                                                                                                                                                                                         | 17/02/2005   | 23/02/2005   |                                |                                                                                     |

## MINOR CHANGES 3

| No      | Scope                                                                                                                                                                                                   | Product Information affected 2   | Date 4     |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------|------------|
| N/0026  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                        | PL                               | 11/09/2007 |
| IA/0025 | product 12_a_Change in spec. of active subst./agent used in manuf. of active subst. - tightening of spec. 37_a_Change in the specification of the finished product - tightening of specification limits |                                  | 22/02/2007 |
| IB/0023 | 38_b_Change in test procedure of finished product - minor change, biol. active subst./excipient                                                                                                         |                                  | 29/08/2006 |
| IB/0022 | 12_a_Change in spec. of active subst./agent used in manuf. of active subst. - tightening                                                                                                                |                                  | 04/08/2006 |
| IA/0021 | 12_a_Change in spec. of active subst./agent used in manuf. of active subst. - tightening of spec.                                                                                                       |                                  | 30/06/2006 |
| IA/0018 | 01_Change in the name and/or address of the marketing authorisation holder                                                                                                                              | SPC, Labelling, PL               | 14/03/2005 |

3 Minor changes e.g. Type I variations and Notifications

4 Date of entry into force of the change

Medicinal product no longer authorised 2/2